Lv43
420 积分 2025-01-07 加入
Computational Pharmacokinetics
1天前
已完结
Assessing DDI risks in drug discovery and development: approaches, challenges, and trends
5天前
已完结
Impact of Interindividual Differences in Plasma Fraction Unbound on the Pharmacokinetics of a Novel Syk Kinase Inhibitor in Beagle Dogs
9天前
已完结
Assessing Cytochrome P450 Time-Dependent Inhibition (IC50 Shift Assay) Using Both Diluted and Non-Diluted Methods
20天前
已完结
Cytochrome P450
20天前
已完结
Preclinical pharmacokinetics, disposition, and translational pharmacokinetic/pharmacodynamic modeling of savolitinib, a novel selective cMet inhibitor
26天前
已完结
Kinetic solubility: Experimental and machine‐learning modeling perspectives
4个月前
已完结
Applications of contemporary tools to measure plasma protein binding of targeted protein degraders
4个月前
已完结
Applications of contemporary tools to measure plasma protein binding of targeted protein degraders
4个月前
已完结
Modeling Human Cytochrome P450 2D6 Metabolism and Drug-Drug Interaction by a Novel Panel of Knockout and Humanized Mouse Lines
5个月前
已完结
皖公网安备34019202002308
